Today the folks in Indy are not just celebrating the Colts victory yesterday they are also celebrating the 36th anniversary of the FDA’s approval of Humulin. The approval process of this drug was outlined in a nice piece written by Henry Miller in today’s Wall Street Journal. Dr. Miller was the founding director of the Office of Biotechnology at the FDA. In the piece Dr. Miller writes;
“The back story, however, is revealing. My team and I were ready to recommend approval after four months’ review. But when I took the packet to my supervisor, he said, “Four . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.